XML 21 R9.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2020
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

3.           STOCK-BASED COMPENSATION

We measure stock-based compensation expense based on the grant date fair value of the awards, which is then recognized over the period which service is required to be provided. We estimate the value of our stock option awards on the date of grant using the Black-Scholes option pricing model (“Black-Scholes”) and amortize that cost over the expected term of the grant. We recognized $73,986 and $49,839 in stock-based compensation expense for the three months ended September 30, 2020 and 2019, respectively. We recognized $270,258 and $219,901 in stock-based compensation expense for the nine months ended September 30, 2020 and 2019, respectively. We issued 2,130,000 stock options to employees, consultants and directors during the nine months ended September 30, 2020 and 2,415,000 stock options to employees, consultants and directors during the nine months ended September 30, 2019. We used the following forward-looking range of assumptions to value the stock options issued in 2020 and 2019:

 

 

 

 

 

 

 

 

    

2020

    

2019

 

Dividend yield

 

0.0

%

0.0

%

Risk-free rate of return

 

0.33

%

2.15

%

Expected life in years

 

5.88

 

5.88

 

Volatility

 

74.57

%

93.59

%

Forfeiture rate

 

2.6

%

2.6

%

 

 

A summary of the Company’s stock options for the nine months ended September 30, 2020 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted

 

Remaining

 

 

 

 

 

Number of

 

Average

 

Contractual

 

Aggregate

 

    

Shares

    

Exercise Price

    

Life

    

Intrinsic Value

Options Outstanding, December 31, 2019

 

9,821,250

 

$

0.28

 

  

 

 

  

Granted

 

2,130,000

 

$

0.30

 

  

 

 

  

Exercised

 

 —

 

$

 —

 

  

 

 

  

Forfeited

 

 —

 

$

 —

 

  

 

 

  

Options Outstanding, September 30, 2020

 

11,951,250

 

$

0.28

 

5.6

years

$

1,637,700

Vested and unvested but expected to vest, September 30, 2020

 

11,811,875

 

$

0.28

 

5.6

years

$

1,618,615

Exercisable at September 30, 2020

 

8,745,500

 

$

0.29

 

4.4

years

$

1,172,288

 

The average expected life was determined using historical data. We expect to recognize the compensation cost related to non-vested options as of September 30, 2020 of $484,486 over the weighted average remaining recognition period of 1.23 years.